These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17428628)
1. Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers. Markatou E; Gionis V; Chryssikos GD; Hatziantoniou S; Georgopoulos A; Demetzos C Int J Pharm; 2007 Jul; 339(1-2):231-6. PubMed ID: 17428628 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123 [TBL] [Abstract][Full Text] [Related]
3. Bundling and aggregation of DNA by cationic dendrimers. Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors. Hadjidemetriou M; Pippa N; Pispas S; Demetzos C J Liposome Res; 2013 Jun; 23(2):94-100. PubMed ID: 23294394 [TBL] [Abstract][Full Text] [Related]
5. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932 [TBL] [Abstract][Full Text] [Related]
6. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Yiyun C; Tongwen X Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746 [TBL] [Abstract][Full Text] [Related]
7. Solubility of nicotinic acid in polyamidoamine dendrimer solutions. Yiyun C; Tongwen X Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352 [TBL] [Abstract][Full Text] [Related]
9. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Patri AK; Kukowska-Latallo JF; Baker JR Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Shi W; Dolai S; Rizk S; Hussain A; Tariq H; Averick S; L'Amoreaux W; El ldrissi A; Banerjee P; Raja K Org Lett; 2007 Dec; 9(26):5461-4. PubMed ID: 18020348 [TBL] [Abstract][Full Text] [Related]
11. Kinetic and equilibrium binding analysis of protein-ligand interactions at poly(amidoamine) dendrimer monolayers. Hong MY; Lee D; Kim HS Anal Chem; 2005 Nov; 77(22):7326-34. PubMed ID: 16285682 [TBL] [Abstract][Full Text] [Related]
12. Amine functionalization of cholecyst-derived extracellular matrix with generation 1 PAMAM dendrimer. Chan JC; Burugapalli K; Naik H; Kelly JL; Pandit A Biomacromolecules; 2008 Feb; 9(2):528-36. PubMed ID: 18198835 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Papagiannaros A; Dimas K; Papaioannou GT; Demetzos C Int J Pharm; 2005 Sep; 302(1-2):29-38. PubMed ID: 16099117 [TBL] [Abstract][Full Text] [Related]
14. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Kitchens KM; El-Sayed ME; Ghandehari H Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076 [TBL] [Abstract][Full Text] [Related]
16. Enhancing amine terminals in an amine-deprived collagen matrix. Tiong WH; Damodaran G; Naik H; Kelly JL; Pandit A Langmuir; 2008 Oct; 24(20):11752-61. PubMed ID: 18774827 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia. Kulhari H; Kulhari DP; Prajapati SK; Chauhan AS Mol Pharm; 2013 Jul; 10(7):2528-33. PubMed ID: 23692066 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates. Najlah M; Freeman S; Attwood D; D'Emanuele A Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118 [TBL] [Abstract][Full Text] [Related]
19. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. Majoros IJ; Thomas TP; Mehta CB; Baker JR J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993 [TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen. Yiyun C; Tongwen X; Rongqiang F Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]